MLH1 and colorectal carcinoma: Although there are already several studies about the clinical significance of specific DDR genes, such as BRCA1/2, POLE, POLD1, and MLH1 (26–31), studies about correlations of DDR pathway somatic mutations with the prognosis of CRC that consider the DDR pathways as a whole are still lacking.